Healthcare & Life Sciences
Y-mAbs Therapeutics
United Stateswww.ymabs.com/
Y-mAbs Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Y-mAbs Therapeutics
Y-mAbs Therapeutics is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Y-mAbs Therapeutics develops and commercializes antibody-based and radioimmunotherapy treatments targeting difficult-to-treat cancers, including its marketed product DANYELZA (naxitamab) for high-risk neuroblastoma.
Explore Y-mAbs Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.